Eating within a window may shield breast cancer Survivors' brains and hearts
NCT ID NCT07259434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether time-restricted eating (eating only during certain hours) can improve heart and brain health in 152 women aged 60-85 who finished chemotherapy for early-stage breast cancer at least a year ago. Participants will get counselling on when to eat and how to get enough protein. The goal is to see if this approach can lower heart disease risk and slow down memory and thinking problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Time restricted eating (TRE) with protein intake counselling
- What this could lead to
- If it works, this could point toward a lifestyle approach to protect heart and brain health in older breast cancer survivors after chemotherapy.
- What could go wrong
- This is a small, early-stage study (152 participants) testing a behavioural change, not a drug. Results may not apply to all survivors, and sticking to the eating schedule may be hard for some.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 152 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 to 85 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * female * aged 60-85 years * BMI ≥25 kg/m2 * diagnosed with early-stage (I-III) BC in the past 15 years * received chemotherapy treatment that was completed ≥1 year earlier * Montreal Cognitive Assessment (MoCA) score of 10-30 which aligns with no impairment to moderate impairment thresholds. Exclusion Criteria: * does not have a mobile device that connects to Bluetooth and can send/receive text messages * history of physician-diagnosed heart disease, dementia or Alzheimer's disease, diabetes that requires insulin or sulfonylurea usage, or eating disorder * MoCA total score \<10 (indicating dementia) * ≥5kg weight change within past 3 months * taking lipid- or weight-lowering medication (e.g. statins or GLP-1 agonists) * high-risk for malnutrition (≥3 on the Malnutrition Screening Tool) * research MRI contraindications (e.g., pacemaker, breast tissue expander, magnetic implants) * eating all daily calories in \<10h/d in the past 3 months * following a structured dietary practice (e.g., ketogenic diet, Weight Watchers) or actively trying to lose weight in the past 3 months * being unable to make adjustments to eating time or nutrient intake * regularly doing \>90 min/week of moderate physical activity in the past 3 months * severe claustrophobia * BMI\>40 kg/m2 (due to body habitus fit within MRI scanner bore) * major psychiatric disorders (e.g. bipolar, post-traumatic stress disorder, schizophrenia) * neurological disorders that significantly impact physical or cognitive function (epilepsy, stroke, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, muscular dystrophy) or traumatic brain injury resulting in ongoing neurological deficits. If the screening process identifies patients with undiagnosed severe cognitive function (MoCA score \<10) or at high risk for malnutrition (≥3 on the Malnutrition Screening Tool), the investigators will recommend that the individual see their family physician. In this process, the investigators will ask the participant if there is a family member that can also receive this information.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Toronto
Toronto, Ontario, M5S 2C9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?